CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- S-4 Deal Registration Statement - Business Combination
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 10-K Report Annual Report
- 8-K Event Agreement ended · Results of operations · Executive or director change
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure
Page 10 of 41 · 808 filings